About FDA
Percentage of orphan drug designation reviews completed in 90 days or less
Dictionary: OOPD will track the time it takes to complete the review of each Orphan Drug designation application. OOPD’s goal is to provide all applicants with a complete and comprehensive review in a timely manner by monitoring the incoming workload and allocating resources as needed. The target review percentages per the noted review periods will continue to ensure high quality service to OOPD orphan drug applicant customers.
Information is current as of December 31, 2012.
Fiscal Year - 2012
| Time | Target | Percentage |
|---|---|---|
| Oct 2011 | 75 | 100 |
| Nov 2011 | 75 | 89 |
| Dec 2011 | 75 | 85 |
| Jan 2012 | 75 | 76 |
| Feb 2012 | 75 | 66 |
| Mar 2012 | 75 | 80 |
| Apr 2012 | 75 | 87 |
| May 2012 | 75 | 86 |
| Jun 2012 | 75 | 67 |
| Jul 2012 | 75 | 87 |
| Aug 2012 | 75 | 100 |
| Sep 2012 | 75 | 87 |
FY 2012 YTD: 83%
Total number of orphan drug designation reviews completed in 90 days or less
Fiscal Year - 2012
| Time | Target | Number of Reviews |
|---|---|---|
| Oct 2011 | N/A | 26 |
| Nov 2011 | N/A | 17 |
| Dec 2011 | N/A | 28 |
| Jan 2012 | N/A | 13 |
| Feb 2012 | N/A | 25 |
| Mar 2012 | N/A | 41 |
| Apr 2012 | N/A | 20 |
| May 2012 | N/A | 18 |
| Jun 2012 | N/A | 20 |
| Jul 2012 | N/A | 45 |
| Aug 2012 | N/A | 18 |
| Sep 2012 | N/A | 45 |
FY 2012 YTD: 316
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
